Market competition has driven hepatitis C drug prices down, but treatment is still too costly for many: Only one in 7 Americans diagnosed with HCV in the highest risk group has been cured, according to a study. If you’re looking for affordable access to these meds, read on. |
|
No comments:
Post a Comment